• Home
  • Search
  • Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study.
  • Cite Icon36
  • https://doi.org/10.1002/btpr.2413Copy DOI Icon

Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Affordability of biopharmaceuticals continues to be a challenge, particularly in developing economies. This has fuelled advancements in manufacturing that can offer higher productivity and better economics without sacrificing product quality in the form of an integrated continuous manufacturing platform. While platform processes for monoclonal antibodies have existed for more than a decade, development of an integrated continuous manufacturing process for bacterial proteins has received relatively scant attention. In this study, we propose an end-to-end integrated continuous downstream process (from inclusion bodies to unformulated drug substance) for a therapeutic protein expressed in Escherichia coli as inclusion body. The final process consisted of a continuous refolding in a coiled flow inverter reactor directly coupled to a three-column periodic counter-current chromatography for capture of the product followed by a three-column con-current chromatography for polishing. The continuous bioprocessing train was run uninterrupted for 26 h to demonstrate its capability and the resulting output was analyzed for the various critical quality attributes, namely product purity (>99%), high molecular weight impurities (<0.5%), host cell proteins (<100 ppm), and host cell DNA (<10 ppb). All attributes were found to be consistent over the period of operation. The developed assembly offers smaller facility footprint, higher productivity, fewer hold steps, and significantly higher equipment and resin utilization. The complexities of process integration in the context of continuous processing have been highlighted. We hope that the study presented here will promote development of highly efficient, universal, end-to-end, fully continuous platforms for manufacturing of biotherapeutics. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:998-1009, 2017.

Similar Papers
  • Research Article
  • Citations4

Isolation and purification of a monoclonal antibody from a cell culture supernatant by multistage precipitation and solid-liquid extraction

  • Jun 06, 2024
  • Food and Bioproducts Processing
  • Tomasz Rumanek +3
  • PDF
  • Research Article
  • Citations14

The effect of feed quality due to clarification strategy on the design and performance of protein A periodic counter-current chromatography.

  • Oct 03, 2018
  • Biotechnology progress
  • Hani El-Sabbahy +5
  • Research Article
  • Citations27

Capillary electrophoresis analysis of isomeric truxillines and other high molecular weight impurities in illicit cocaine.

  • Jan 01, 1998
  • ELECTROPHORESIS
  • Ira S Lurie +6
  • Research Article

Studies on intracytoplasmic crystalline inclusion bodies in parietal cells of fattened steers. I. Occurrence rate and ultrastructure of inclusion body.

  • Jan 01, 1981
  • Nihon juigaku zasshi. The Japanese journal of veterinary science
  • Yutaka Chihaya +2
  • Research Article
  • Citations72

Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).

  • Aug 27, 2015
  • Analytical Chemistry
  • Amy Farrell +6
  • Research Article
  • Citations54

Relation between cell disruption conditions, cell debris particle size, and inclusion body release.

  • Sep 24, 2004
  • Biotechnology and Bioengineering
  • Pim Van Hee +3
  • Research Article
  • Citations4

Mammalian Orthoreovirus Reassortment Proceeds with Little Constraint on Segment Mixing.

  • Dec 22, 2021
  • Journal of virology
  • Megan R Hockman +4
  • Research Article
  • Citations273

Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.

  • Mar 01, 2000
  • Protein Expression and Purification
  • Ashok K Patra +5
  • Research Article
  • Citations4

Lead-Induced Inclusion Bodies: Composition and Probable Role in Lead Metabolism

  • May 01, 1974
  • Environmental Health Perspectives
  • John F Moore +1
  • Book Chapter
  • Citations6

Digital design and optimization of an integrated reaction-extraction-crystallization-filtration continuous pharmaceutical process

  • Jan 01, 2022
  • Computer Aided Chemical Engineering
  • Timothy J.S Campbell +2
  • Research Article
  • Citations13

KURLOFF CELLS.

  • Jul 01, 1976
  • Acta Pathologica Microbiologica Scandinavica Section A Pathology
  • Leena Kortelainen +1
  • Research Article
  • Citations59

Localization and characterization of inclusion bodies in recombinant Escherichia coli cells overproducing penicillin G acylase.

  • Apr 14, 1997
  • Applied Microbiology and Biotechnology
  • N Sriubolmas +3
  • Research Article
  • Citations26

Polypeptides associated with inclusion bodies from leaves of turnip infected with cauliflower mosaic virus

  • Sep 01, 1980
  • Virology
  • M.W Shockey +3
  • Book Chapter
  • Citations13

Advanced Control of Continuous Pharmaceutical Tablet Manufacturing Processes

  • Jan 01, 2016
  • Ravendra Singh +6
  • PDF
  • Research Article
  • Citations22

Retinoid Binding Properties of Nucleotide Binding Domain 1 of the Stargardt Disease-associated ATP Binding Cassette (ABC) Transporter, ABCA4

  • Dec 01, 2012
  • Journal of Biological Chemistry
  • Esther E Biswas-Fiss +3
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.